Mitsuyoshi Azuma
Direttore/Membro del Consiglio presso Senju Pharmaceutical Co., Ltd.
Profilo
Mitsuyoshi Azuma is currently a Director & Managing Executive Officer at Senju Pharmaceutical Co., Ltd.
and a Director at Neuroptika, Inc. He was formerly a Director at SemaThera, Inc.
Posizioni attive di Mitsuyoshi Azuma
| Società | Posizione | Inizio |
|---|---|---|
Senju Pharmaceutical Co., Ltd.
 Senju Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Senju Pharmaceutical Co., Ltd. manufactures and distributes pharmaceuticals. It produces drugs for inflammation, allergy, glaucoma, cataract, and infection. The company was founded on April 9, 1947 and is headquartered in Osaka, Japan. | Direttore/Membro del Consiglio | - |
Neuroptika, Inc.
 Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Mitsuyoshi Azuma
| Società | Posizione | Fine |
|---|---|---|
SemaThera, Inc.
 SemaThera, Inc. BiotechnologyHealth Technology SemaThera, Inc. engages in research and development in biotechnology. It develops novel inhibitors against semaphorin 3A (SEMA 3A) for prevention and reversal of diabetic macular edema (DME). The company is headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Senju Pharmaceutical Co., Ltd.
Senju Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Senju Pharmaceutical Co., Ltd. manufactures and distributes pharmaceuticals. It produces drugs for inflammation, allergy, glaucoma, cataract, and infection. The company was founded on April 9, 1947 and is headquartered in Osaka, Japan. | Health Technology |
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Health Technology |
SemaThera, Inc.
SemaThera, Inc. BiotechnologyHealth Technology SemaThera, Inc. engages in research and development in biotechnology. It develops novel inhibitors against semaphorin 3A (SEMA 3A) for prevention and reversal of diabetic macular edema (DME). The company is headquartered in Montreal, Canada. | Health Technology |
- Borsa valori
- Insiders
- Mitsuyoshi Azuma
